<DOC>
	<DOCNO>NCT01639300</DOCNO>
	<brief_summary>The purpose study assess safety tolerability single ascending dos , well repeat administration GNbAC1 MS patient . Scientific research show expression gene virus integrated Human genetic material , Multiple Sclerosis associate RetroVirus ( MSRV ) could play critical role causation multiple sclerosis . GNbAC1 experimental medication , neutralizes ( i.e . inactivates ) protein MSRV might contribute development deterioration multiple sclerosis .</brief_summary>
	<brief_title>Safety Study GNbAC1 Multiple Sclerosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Male female patient ( female , neither pregnant breastfeeding , postmenopausal surgically sterile , use two highly effective method contraception oral contraception plus mechanical barrier ) ; Male subject partner childbearing potential use adequate contraception study . Contraception method follow study 3 month last study drug administration . Female subject woman childbearing potential ( WOCBP ) test negative pregnancy test ( serum urine ) screen Day 1 repeat administration GNbAC1 . Between 18 65 year age ; Patients Primary Progressive MS ( PPMS ) accord Revised McDonald criterion 2010 patient Secondary Progressive MS ( SPMS ) patient RelapsingRemitting MS ( RRMS ) accord Revised McDonald criterion 2010 treat available treatment MS due intolerance , non response refusal treatment ; Score â‰¤ 6.5 Expanded Disability Status Scale ( EDSS ) ; Body weight 40 100kg . Positive serology viral hepatitis HIV ; Disease MS could better explain his/her sign symptom ; Previously treat cladribine , lymphoid irradiation deplete antibody ; Usage last 3 month interferon beta glatiramer acetate ; Any usage last 6 month mitoxantrone , cytotoxic immunosuppressive therapy , natalizumab , fingolimod immunoglobulin ; Usage within 30 day prior baseline oral systemic corticosteroid ACTH ; Inadequate liver function ; Severe renal impairment ; Severe psychiatric disorder ; Known inability undergo MRI scan ; Having participate another clinical study within 6 month prior study baseline except patient participate currently participate interventional study without study drug intake . Pregnancy breastfeed Female subject consider become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Relapsing Forms Multiple Sclerosis</keyword>
	<keyword>Progressive Forms Multiple Sclerosis</keyword>
	<keyword>GNbAC1</keyword>
	<keyword>Monoclonal antibody</keyword>
	<keyword>Multiple Sclerosis Associated Retrovirus ( MSRV )</keyword>
</DOC>